A small, randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome [3]

Clinical Infectious Diseases

Volumn 32, Issue 11, 2001, Pages 1657-1658

  Lerner, A Martin ^a   Zervos, Marcus ^a   Chang, C H ^a   Beqaj, Safedin ^a   Goldstein, James ^a   O'Neill, William ^a   Dworkin, Howard ^a   Fitgerald, Thomas ^b   Deeter, Robert G ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIVIRUS AGENT; GANCICLOVIR; IMMUNOGLOBULIN M; PLACEBO; VALACICLOVIR;

CARDIOMYOPATHY; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HEART EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART VENTRICLE FUNCTION; HERPES VIRUS; HUMAN; IMMUNOBLOTTING; LETTER; PERSISTENT INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADULT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CROSS-OVER STUDIES; CYTOMEGALOVIRUS INFECTIONS; DOUBLE-BLIND METHOD; EPSTEIN-BARR VIRUS INFECTIONS; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE;

EID: 0035370308     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320530     Document Type: Letter

References (8)